vs

Side-by-side financial comparison of MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) and Repay Holdings Corp (RPAY). Click either name above to swap in a different company.

Repay Holdings Corp is the larger business by last-quarter revenue ($78.6M vs $49.9M, roughly 1.6× MARAVAI LIFESCIENCES HOLDINGS, INC.). MARAVAI LIFESCIENCES HOLDINGS, INC. runs the higher net margin — -71.6% vs -178.3%, a 106.7% gap on every dollar of revenue. On growth, Repay Holdings Corp posted the faster year-over-year revenue change (0.4% vs -11.8%). Repay Holdings Corp produced more free cash flow last quarter ($23.2M vs $-24.9M). Over the past eight quarters, Repay Holdings Corp's revenue compounded faster (-1.3% CAGR vs -11.9%).

Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.

Repay Holdings Corp is a leading payment technology provider delivering integrated end-to-end payment processing solutions for businesses across North America. Its offerings include credit/debit card processing, ACH transfer services, POS system integrations and digital payment tools, serving retail, healthcare, automotive and e-commerce segments to help clients streamline transaction workflows and boost operational efficiency.

MRVI vs RPAY — Head-to-Head

Bigger by revenue
RPAY
RPAY
1.6× larger
RPAY
$78.6M
$49.9M
MRVI
Growing faster (revenue YoY)
RPAY
RPAY
+12.2% gap
RPAY
0.4%
-11.8%
MRVI
Higher net margin
MRVI
MRVI
106.7% more per $
MRVI
-71.6%
-178.3%
RPAY
More free cash flow
RPAY
RPAY
$48.1M more FCF
RPAY
$23.2M
$-24.9M
MRVI
Faster 2-yr revenue CAGR
RPAY
RPAY
Annualised
RPAY
-1.3%
-11.9%
MRVI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MRVI
MRVI
RPAY
RPAY
Revenue
$49.9M
$78.6M
Net Profit
$-35.7M
$-140.1M
Gross Margin
25.8%
74.2%
Operating Margin
-117.9%
-182.2%
Net Margin
-71.6%
-178.3%
Revenue YoY
-11.8%
0.4%
Net Profit YoY
-37.7%
-3304.1%
EPS (diluted)
$-0.24
$-1.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRVI
MRVI
RPAY
RPAY
Q4 25
$49.9M
$78.6M
Q3 25
$41.6M
$77.7M
Q2 25
$47.4M
$75.6M
Q1 25
$46.9M
$77.3M
Q4 24
$56.6M
$78.3M
Q3 24
$69.0M
$79.1M
Q2 24
$69.4M
$74.9M
Q1 24
$64.2M
$80.7M
Net Profit
MRVI
MRVI
RPAY
RPAY
Q4 25
$-35.7M
$-140.1M
Q3 25
$-25.6M
$-6.4M
Q2 25
$-39.6M
$-102.3M
Q1 25
$-29.9M
$-7.9M
Q4 24
$-25.9M
$-4.1M
Q3 24
$-97.1M
$3.2M
Q2 24
$-9.8M
$-4.1M
Q1 24
$-12.1M
$-5.2M
Gross Margin
MRVI
MRVI
RPAY
RPAY
Q4 25
25.8%
74.2%
Q3 25
13.6%
74.4%
Q2 25
16.4%
75.7%
Q1 25
16.5%
75.9%
Q4 24
34.3%
76.3%
Q3 24
46.7%
77.8%
Q2 24
44.4%
78.2%
Q1 24
40.3%
76.2%
Operating Margin
MRVI
MRVI
RPAY
RPAY
Q4 25
-117.9%
-182.2%
Q3 25
-98.6%
-3.9%
Q2 25
-139.8%
-138.7%
Q1 25
-104.9%
-4.7%
Q4 24
-66.7%
-1.5%
Q3 24
-239.9%
-0.9%
Q2 24
-19.4%
-4.6%
Q1 24
-29.4%
-3.1%
Net Margin
MRVI
MRVI
RPAY
RPAY
Q4 25
-71.6%
-178.3%
Q3 25
-61.4%
-8.3%
Q2 25
-83.5%
-135.2%
Q1 25
-63.9%
-10.3%
Q4 24
-45.8%
-5.3%
Q3 24
-140.6%
4.1%
Q2 24
-14.1%
-5.4%
Q1 24
-18.8%
-6.5%
EPS (diluted)
MRVI
MRVI
RPAY
RPAY
Q4 25
$-0.24
$-1.68
Q3 25
$-0.18
$-0.08
Q2 25
$-0.27
$-1.15
Q1 25
$-0.21
$-0.09
Q4 24
$-0.21
$-0.04
Q3 24
$-0.68
$0.03
Q2 24
$-0.07
$-0.04
Q1 24
$-0.09
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRVI
MRVI
RPAY
RPAY
Cash + ST InvestmentsLiquidity on hand
$216.9M
$115.7M
Total DebtLower is stronger
$291.8M
$280.1M
Stockholders' EquityBook value
$212.4M
$484.4M
Total Assets
$770.6M
$1.2B
Debt / EquityLower = less leverage
1.37×
0.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRVI
MRVI
RPAY
RPAY
Q4 25
$216.9M
$115.7M
Q3 25
$243.6M
$95.7M
Q2 25
$269.9M
$162.6M
Q1 25
$285.1M
$165.5M
Q4 24
$322.4M
$189.5M
Q3 24
$578.2M
$168.7M
Q2 24
$573.2M
$147.1M
Q1 24
$561.7M
$128.3M
Total Debt
MRVI
MRVI
RPAY
RPAY
Q4 25
$291.8M
$280.1M
Q3 25
$292.8M
$279.5M
Q2 25
$293.9M
$279.0M
Q1 25
$294.9M
$497.6M
Q4 24
$295.9M
$496.8M
Q3 24
$521.7M
$496.2M
Q2 24
$522.5M
$435.6M
Q1 24
$523.3M
$434.9M
Stockholders' Equity
MRVI
MRVI
RPAY
RPAY
Q4 25
$212.4M
$484.4M
Q3 25
$245.4M
$616.9M
Q2 25
$265.9M
$633.7M
Q1 25
$300.6M
$755.7M
Q4 24
$325.3M
$761.3M
Q3 24
$344.9M
$754.7M
Q2 24
$434.7M
$815.4M
Q1 24
$410.7M
$813.8M
Total Assets
MRVI
MRVI
RPAY
RPAY
Q4 25
$770.6M
$1.2B
Q3 25
$849.2M
$1.3B
Q2 25
$897.0M
$1.4B
Q1 25
$959.8M
$1.5B
Q4 24
$1.0B
$1.6B
Q3 24
$1.3B
$1.6B
Q2 24
$1.4B
$1.5B
Q1 24
$1.4B
$1.5B
Debt / Equity
MRVI
MRVI
RPAY
RPAY
Q4 25
1.37×
0.58×
Q3 25
1.19×
0.45×
Q2 25
1.11×
0.44×
Q1 25
0.98×
0.66×
Q4 24
0.91×
0.65×
Q3 24
1.51×
0.66×
Q2 24
1.20×
0.53×
Q1 24
1.27×
0.53×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MRVI
MRVI
RPAY
RPAY
Operating Cash FlowLast quarter
$-22.8M
$23.3M
Free Cash FlowOCF − Capex
$-24.9M
$23.2M
FCF MarginFCF / Revenue
-49.9%
29.6%
Capex IntensityCapex / Revenue
4.2%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-70.7M
$90.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MRVI
MRVI
RPAY
RPAY
Q4 25
$-22.8M
$23.3M
Q3 25
$-15.2M
$32.2M
Q2 25
$-10.3M
$33.1M
Q1 25
$-9.4M
$2.5M
Q4 24
$-14.6M
$34.3M
Q3 24
$13.1M
$60.1M
Q2 24
$17.4M
$31.0M
Q1 24
$-8.5M
$24.8M
Free Cash Flow
MRVI
MRVI
RPAY
RPAY
Q4 25
$-24.9M
$23.2M
Q3 25
$-18.1M
$32.1M
Q2 25
$-13.1M
$33.0M
Q1 25
$-14.6M
$2.4M
Q4 24
$-20.5M
$34.0M
Q3 24
$4.5M
$59.8M
Q2 24
$7.9M
$30.5M
Q1 24
$-14.1M
$24.7M
FCF Margin
MRVI
MRVI
RPAY
RPAY
Q4 25
-49.9%
29.6%
Q3 25
-43.4%
41.3%
Q2 25
-27.7%
43.6%
Q1 25
-31.2%
3.0%
Q4 24
-36.2%
43.5%
Q3 24
6.6%
75.6%
Q2 24
11.4%
40.7%
Q1 24
-22.0%
30.6%
Capex Intensity
MRVI
MRVI
RPAY
RPAY
Q4 25
4.2%
0.1%
Q3 25
7.0%
0.2%
Q2 25
6.1%
0.1%
Q1 25
11.2%
0.2%
Q4 24
10.3%
0.3%
Q3 24
12.4%
0.3%
Q2 24
13.8%
0.6%
Q1 24
8.8%
0.1%
Cash Conversion
MRVI
MRVI
RPAY
RPAY
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
18.52×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MRVI
MRVI

Cygnus Segment$27.2M54%
Other$18.4M37%
Shipping And Handling$4.3M9%

RPAY
RPAY

Sales Channel Directly To Consumer$69.4M88%
Other$6.8M9%
Sales Channel Through Intermediary$2.3M3%

Related Comparisons